5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages ClearNote Health February 2, 2026
Pilot study demonstrating changes in DNA hydroxymethylation enable detection of multiple cancers in plasma cell-free DNA ClearNote Health February 2, 2026
Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA ClearNote Health February 2, 2026
A human tissue map of 5-hydroxymethylcytosines exhibits tissue specificity through gene and enhancer modulation ClearNote Health February 2, 2026
The Cell Type-Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and TET2-Mutant Preleukemia ClearNote Health February 2, 2026
Epigenomic Blood-Based Early Detection of Pancreatic Cancer Employing Cell-Free DNA ClearNote Health February 2, 2026
Plasma cell-free DNA hydroxymethylation profiling reveals anti-PD-1 treatment response and resistance biology in non- small cell lung cancer ClearNote Health February 2, 2026
Analytical Validation of an Early Detection Pancreatic Cancer Test Using 5-Hydroxymethylation Signatures ClearNote Health February 2, 2026
5-hydroxymethylcytosine analysis reveals stable epigenomic changes in tumor tissue that enable cancer detection in cell-free DNA ClearNote Health January 30, 2026
